Premium Information is available for this item - Upgrade for $1 a day
6505-00-973-8502
Usp Warfarin Sodium Tablets
6505009738502 009738502 COUMADIN NDC00056-0172-90
INC: 27974 Warfarin Sodium Tablets
January 2023
5
Marketplace 6505-00-973-8502
Request a Quotation from participating marketplace vendors
Related Documents 6505-00-973-8502 5+ Documents (More...)
6505-00-973-8502 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-973-8502
/fsg-65/fsc-6505/us 6505-00-973-8502 Usp Warfarin Sodium Tablets 6505009738502 www.nsnlookup.com /fsg
Usp Warfarin Sodium Tablets 6505009738502 Warfarin Sodium Tablets 6505270057724 //www.nsnlookup.com
/fsg-65/fsc-6505/tr 6505-27 https//www.nsnlookup.com fsc-6505/us 6505-00-973-8502 Usp Warfarin Sodium
6505002001576 Usp Warfarin Sodium Tablets 6505218461990 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-973-8502
Usp Warfarin Sodium Tablets 6505009738502 Tablets 6505270057724 Usp Warfarin Sodium Tablets https
Usp Warfarin Sodium Tablets 6505002001589 Tablets 6505002545305 https//www.nsnlookup.com https/ 6505009738502
Usp Warfarin Sodium Tablets 6505009738502 Warfarin Sodium Tablets 6505270057724 6505002001589 https/
COUMADIN TABLETS NDC00056-0169-90 Managed by United States NSN Created on 20 Sep 1990 Data Last Changed
www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-052-2857 Usp Warfarin Sodium Tablets 6505010522857 COUMADIN
Restrictions 6505-00-973-8502
6505-00-973-8502 is a Usp Warfarin Sodium Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
Import and Export 6505-00-973-8502
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-00-973-8502
- NASA (G572)
- Effective Date:
- 1 Apr 1991
- MOE Rule:
- V542
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-00-973-8502
- Part Number
- Manufacturer
- Status
- NDC00056-0172-90
- Manufacturer
- 04490 - Bristol-Myers Squibb Pharma Company (Active)
- Primary Buy
- Primary Buy
- COUMADIN
- 04490 - Bristol-Myers Squibb Pharma Company (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-00-973-8502
- Characteristic
- Specifications
- FIIG
- Specifications
- A510N0
- Active Medicament Medicinal Strength [AKJA]
- 5.000 Milligrams Warfarin Sodium Active Ingredient
- Primary Container Type [CQCT]
- Bottle
- Primary Container Content Quantity [CRLK]
- 1000.000 Tablets
- Therapeutic Equivalent [THPE]
- Coumadin,Dupont Pharm.
Management Data 6505-00-973-8502
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- Feb 1994
- Veterans Administration (VA)
- BT
- Subscribe
- 1
- BT
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Veterans Administration (VA)
- V
- K
- U/I Contains 1000 Tt
- 00000001000TT
- K
Similar Supply Items to 6505-00-973-8502
Freight Information 6505-00-973-8502
6505-00-973-8502 has freight characteristics.. 6505-00-973-8502 has a variance between NMFC and UFC when transported by rail and the description should be consulted.